All caps makes your post difficult to read, but your points are clear, you think Cobalis will be very sucessful and that the stock is being held back by naked shorting. I question both points.
As for success, the product failed its phase 3 trial, $300K for a product launch is peanuts, and there is 5M of debt to contend with.
Naked shorting does happen but with Cobalis it is not for sure on a daily basis. Maybe maybe at times of big news but most days the volume is just too low to matter. Today 1550 shares traded.
I like Cobalis, but have a wait and see approach, and am particularly interested to see if the product works.
News 
Market Data 
Discover 
